Finland· FI-REL-REL2240
Mencevax Acwy
A meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen product containing neisseria meningitidis group a polysaccharide + neisseria meningitidis group c polysaccharide + neisseria meningitidis group y polysaccharide + neisseria meningitidis group w135 polysaccharide, registered in Finland by GlaxoSmithKline Biologicals SA. The same ATC class is registered in 3 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen is registered in 3 of 19 countries.
Countries holding a registration under ATC J07AH04 (meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen · ATC J07AH04
3 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Neisseria meningitidis group A polysaccharide + Neisseria meningitidis group C polysaccharide + Neisseria meningitidis group Y polysaccharide + Neisseria meningitidis group W135 polysaccharide
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Country
- Finland (FI)
- ATC code
- J07AH04
- ATC class
- Meningokokken A, C, Y, W-135, tetravalent, gereinigtes Polysaccharid-Antigen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH04
Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eefe4fd4-98c1-455b-9bce-e30a6bef25e5 GET /v1/drugs/eefe4fd4-98c1-455b-9bce-e30a6bef25e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "meningokokkipolysakkaridi A, C, Y, W-135, tetravalentti",
"ma_number": "9645",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL2240",
"authorised_at": "1988-04-20"
}See everything about meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.